Advertisement
Dr. Haseltine currently serves as president of the Haseltine Foundationfor Medical Sciences and the Arts, a foundation that supports access to highquality health for the poor and middle class of developing countries. He isalso the chairman of Haseltine Global Health, LLC, a company dedicated todeveloping life saving drugs and medical devices.
Advertisement
In addition to these positions, he serves as an advisor to CMEA, a venturecapital company, the Reliance Innovation Council, India and to several otherbiotechnology and pharmaceutical companies. Collectively, Dr. Haseltine hasfounded nine successful biotechnology companies including Human GenomeSciences, Inc.
"Dr. Haseltine is one of the industry's most respected and talentedindividuals. His addition to our company is a tremendous testament to thethings we are looking to accomplish as we proceed with the commercializationphase of our operations, and becoming the leading viral disease company," saidShawn Patrick O'Brien, president and CEO of Profectus BioSciences. "Dr.Haseltine will provide strategic insight in helping us enhance and expand ourtechnologies."
Dr. Haseltine also has contributed to the academic community and is wellknown for his pioneering research on cancer, HIV/AIDS and genomics. As aprofessor at Harvard Medical School, he was founder and the chair of twoacademic research departments. Today, he is an adjunct professor at TheScripps Institute for Medical Research and the Institute of ChemicalEngineering the University of Mumbai, India. He is chairman of the Board ofthe Berkeley Center for Synthetic Biology. Dr. Haseltine has published morethan 200 manuscripts in peer reviewed journals and is the author of severalbooks.
"This is a very exciting time for Profectus BioSciences," said Dr.Haseltine. "With its seasoned leadership and innovative technologies, thecompany is perfectly positioned to help improve those who are afflicted withviral diseases. I'm very enthused to be a part of an organization that hasthe resources and expertise to realize this incredible opportunity."
Aside from his professional expertise, Dr. Haseltine is also very activein public service. He is co-chair of the President's Council of the ColdSpring Harbor Laboratory, a member of the Advisory Board of the GlobalCoalition on HIV/AIDS and he is a governor of the New York Academy of Science.He is a member of the Executive Committee of the Brookings Institution, amember of the Council on Foreign Relations, and a member of the Chairman'sCircle of the Asia Society. He is also a founder of the American FreedomCampaign.
About Profectus BioSciences Inc.
Profectus BioSciences Inc. began operations in early 2005 to develop andcommercialize technologies to reduce the morbidity and mortality caused byhuman viral diseases, including the human immunodeficiency virus (HIV), thecausative agent of AIDS. Founded to fulfill the mission of its co-foundersDrs. Gallo, Blattner, and Redfield (collectively, the founders) for"bench-top-to-bedside" medicine, the Company applies its specific scientificexpertise to help commercialize promising unique technologies used for humanand animal health. For more information please visit:www.profectusbiosciences.com.
SOURCE Profectus BioSciences Inc.
